A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Shuzhen Wang et al.|Alzheimer s Research & Therapy|2021Cited by 200
SIRT5 affects lipid accumulation in cells of a metabolic-associated fatty liver disease model by regulating the succinylation status of HSPD1Yang Lü, Bo Xie|BMC Immunology|2025Cited by 2